These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 33038766)
1. HIV vaccines: Unmasking myeloid derived suppressor cells. Green WR; O'Connor MA EBioMedicine; 2020 Nov; 61():103063. PubMed ID: 33038766 [No Abstract] [Full Text] [Related]
2. Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response Liu L; Lin Q; Peng J; Fang J; Tan Z; Tang H; Kwan K; Nishiura K; Liang J; Kwok H; Du Z; Sun J; Liu K; Yuen KY; Wang H; Chen Z EBioMedicine; 2020 Oct; 60():103008. PubMed ID: 32979832 [TBL] [Abstract][Full Text] [Related]
3. Dancing with an escape artist. Deweerdt S Nature; 2010 Jul; 466(7304):S6-7. PubMed ID: 20631705 [No Abstract] [Full Text] [Related]
4. 'Mosaic' HIV vaccine to be tested in thousands of people across the world. Mega ER Nature; 2019 Aug; 572(7768):165-166. PubMed ID: 31388154 [No Abstract] [Full Text] [Related]
5. Honing the T cell response to HIV: Turning off the noise. Landau NR EBioMedicine; 2021 Feb; 64():103217. PubMed ID: 33516065 [No Abstract] [Full Text] [Related]
6. Biomarkers of natural and vaccine immunity against HIV. Keane N; John M Biomark Med; 2011 Apr; 5(2):113-6. PubMed ID: 21473715 [No Abstract] [Full Text] [Related]
7. Systems biology in understanding HIV pathogenesis and guiding vaccine development. Sekaly R; Pulendran B Curr Opin HIV AIDS; 2012 Jan; 7(1):1-3. PubMed ID: 22134343 [No Abstract] [Full Text] [Related]
8. The impact of MDSCs on the efficacy of preventive and therapeutic HIV vaccines. Yaseen MM; Abuharfeil NM; Darmani H Cell Immunol; 2021 Nov; 369():104440. PubMed ID: 34560382 [TBL] [Abstract][Full Text] [Related]
9. Fundamental challenges to the development of a preventive HIV vaccine. Rios A Curr Opin Virol; 2018 Apr; 29():26-32. PubMed ID: 29549802 [TBL] [Abstract][Full Text] [Related]
10. The RV144 Thai HIV vaccine trial. Plotkin SA Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337 [No Abstract] [Full Text] [Related]
11. An HIV vaccine--challenges and prospects. Johnston MI; Fauci AS N Engl J Med; 2008 Aug; 359(9):888-90. PubMed ID: 18753644 [No Abstract] [Full Text] [Related]
12. Modeling the impact of RV144-like vaccines on HIV transmission. Hankins CA; Glasser JW; Chen RT Vaccine; 2011 Aug; 29(36):6069-71. PubMed ID: 21762753 [No Abstract] [Full Text] [Related]
13. Correlates of protection and HIV vaccine development. Akpogheneta O Lancet Infect Dis; 2011 Nov; 11(11):814-5. PubMed ID: 22167821 [No Abstract] [Full Text] [Related]
14. HIV-- tailored to fit. Dell H Drug Discov Today; 2004 Feb; 9(3):101. PubMed ID: 14968761 [No Abstract] [Full Text] [Related]
15. Improving defences at the portal of HIV entry: mucosal and innate immunity. Shattock RJ; Haynes BF; Pulendran B; Flores J; Esparza J; PLoS Med; 2008 Apr; 5(4):e81. PubMed ID: 18384232 [TBL] [Abstract][Full Text] [Related]
17. Researchers announce first correlates of protection for HIV vaccine. Roehr B BMJ; 2011 Sep; 343():d5880. PubMed ID: 21920885 [No Abstract] [Full Text] [Related]